Browse by Journal Title

2025

Multimodal longitudinal optical imaging reveals optic neuritis preceding retinal pathology in experimental autoimmune encephalomyelitis.
Raspe, R., Günther, R., Uecker, R., Rakhymzhan, A., Paul, F., Radbruch, H., Niesner, R.A. and Hauser, A.E.
Neurology Neuroimmunology & Neuroinflammation 12 (1): e200338. January 2025

2024

Diagnostic value of inter-eye difference metrics on OCT for myelin oligodendrocyte glycoprotein antibody-associated optic neuritis.
Volpe, G., Jurkute, N., Girafa, G., Zimmermann, H.G., Motamedi, S., Bereuter, C., Pandit, L., D'Cunha, A., Yeaman, M.R., Smith, T.J., Cook, L.J., Brandt, A.U., Paul, F., Petzold, A. and Oertel, F.C.
Neurology Neuroimmunology & Neuroinflammation 11 (6): e200291. November 2024

Individual prognostication of disease activity and disability worsening in multiple sclerosis with retinal layer thickness z scores.
Lin, T.Y., Motamedi, S., Asseyer, S., Chien, C., Saidha, S., Calabresi, P.A., Fitzgerald, K.C., Samadzadeh, S., Villoslada, P., Llufriu, S., Green, A.J., Preiningerova, J.L., Petzold, A., Leocani, L., Garcia-Martin, E., Oreja-Guevara, C., Outteryck, O., Vermersch, P., Balcer, L.J., Kenney, R., Albrecht, P., Aktas, O., Costello, F., Frederiksen, J., Uccelli, A., Cellerino, M., Frohman, E.M., Frohman, T.C., Bellmann-Strobl, J., Schmitz-Hübsch, T., Ruprecht, K., Brandt, A.U., Zimmermann, H.G. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 11 (5): e200269. September 2024

Retinal changes in double-antibody seronegative neuromyelitis optica spectrum disorders.
Oertel, F.C., Zimmermann, H.G., Motamedi, S., Bereuter, C., Manthey, L.M., Ashtari, F., Kafieh, R., Dehghani, A., Pourazizi, M., Pandit, L., D'Cunha, A., Aktas, O., Albrecht, P., Ringelstein, M., Martinez-Lapiscina, E.H., Sanchez Dalmau, B.F., Villoslada, P., Asgari, N., Marignier, R., Cobo-Calvo, A., Leocani, L., Pisa, M., Radaelli, M., Palace, J., Roca-Fernandez, A., Leite, M.I.S., Sharma, S., De Seze, J., Senger, T., Yeaman, M.R., Smith, T.J., Cook, L.J., Brandt, A.U. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 11 (5): e200273. September 2024

Serum proteomics distinguish subtypes of NMO spectrum disorder and MOG antibody-associated disease and highlight effects of B-cell depletion.
Gawde, S., Siebert, N., Ruprecht, K., Kumar, G., Ko, R.M., Massey, K., Guthridge, J.M., Mao-Draayer, Y., Schindler, P., Hastermann, M., Pardo, G., Paul, F. and Axtell, R.C.
Neurology Neuroimmunology & Neuroinflammation 11 (4): e200268. July 2024

Clinical characterization and ancillary tests in Susac syndrome: a systematic review.
Wilf-Yarkoni, A., Zmira, O., Tolkovsky, A., Pflantzer, B., Gofrit, S.G., Kleffner, I., Paul, F. and Dörr, J.
Neurology Neuroimmunology & Neuroinflammation 11 (3): e200209. May 2024

2023

The OSCAR-MP consensus criteria for quality assessment of retinal optical coherence tomography angiography.
Wicklein, R., Yam, C., Noll, C., Aly, L., Banze, N., Romahn, E.F., Wolf, E., Hemmer, B., Oertel, F.C., Zimmermann, H., Albrecht, P., Ringelstein, M., Baumann, C., Feucht, N., Penkava, J., Havla, J., Gernert, J.A., Mardin, C., Vasileiou, E.S., Van Der Walt, A., Al-Louzi, O., Cabello, S., Vidal-Jordana, A., Krämer, J., Wiendl, H., Preiningerova, J.L., Ciccarelli, O., Garcia-Martin, E., Kana, V., Calabresi, P.A., Paul, F., Saidha, S., Petzold, A., Toosy, A.T. and Knier, B.
Neurology Neuroimmunology & Neuroinflammation 10 (6): e200169. November 2023

International delphi consensus on the management of AQP4-IgG+ NMOSD: recommendations for eculizumab, inebilizumab, and satralizumab.
Paul, F., Marignier, R., Palace, J., Arrambide, G., Asgari, N., Bennett, J.L., Cree, B.A.C., De Sèze, J., Fujihara, K., Kim, H.J., Hornby, R., Huda, S., Kissani, N., Kleiter, I., Kuwabara, S., Lana-Peixoto, M., Law, L., Leite, M.I., Pandit, L., Pittock, S.J., Quan, C., Ramanathan, S., Rotstein, D., Saiz, A., Sato, D.K. and Vaknin-Dembinsky, A.
Neurology Neuroimmunology & Neuroinflammation 10 (4): e200124. July 2023

Visually evoked potential as prognostic biomarker for neuroaxonal damage in multiple sclerosis from a multicenter longitudinal cohort.
Oertel, F.C., Krämer, J., Motamedi, S., Keihani, A., Zimmermann, H.G., Dimitriou, N.G., Condor-Montes, S., Bereuter, C., Cordano, C., Abdelhak, A., Trip, A., Aktas, O., Meuth, S.G., Wiendl, H., Ruprecht, K., Bellmann-Strobl, J., Paul, F., Petzold, A., Brandt, A.U., Albrecht, P. and Green, A.J.
Neurology Neuroimmunology & Neuroinflammation 10 (3): e200092. May 2023

Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases: COPANMO(G)-Study.
Hümmert, M.W., Bütow, F., Tkachenko, D., Ayzenberg, I., Pakeerathan, T., Hellwig, K., Klotz, L., Häußler, V., Stellmann, J.P., Warnke, C., Goereci, Y., Etgen, T., Luessi, F., Bronzlik, P., Gingele, S., Lauenstein, A.S., Kleiter, I., Rommer, P.S., Paul, F., Bellmann-Strobl, J., Duchow, A., Then Bergh, F., Pul, R., Walter, A., Pellkofer, H., Kümpfel, T., Pompsch, M., Kraemer, M., Albrecht, P., Aktas, O., Ringelstein, M., Senel, M., Giglhuber, K., Berthele, A., Jarius, S., Wildemann, B. and Trebst, C.
Neurology Neuroimmunology & Neuroinflammation 10 (2): e200082. March 2023

N2 year in review.
Dalmau, J., Dalakas, M.C., Kolson, D.L., Paul, F., Sánchez-Valle, R. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 10 (1): e200076. January 2023

2022

Choroid plexus volume in multiple sclerosis vs neuromyelitis optica spectrum disorder: a retrospective, cross-sectional analysis.
Müller, J., Sinnecker, T., Wendebourg, M.J., Schläger, R., Kuhle, J., Schädelin, S., Benkert, P., Derfuss, T., Cattin, P., Jud, C., Spiess, F., Amann, M., Lincke, T., Barakovic, M., Cagol, A., Tsagkas, C., Parmar, K., Pröbstel, A.K., Reimann, S., Asseyer, S., Duchow, A., Brandt, A., Ruprecht, K., Hadjikhani, N., Fukumoto, S., Watanabe, M., Masaki, K., Matsushita, T., Isobe, N., Kira, J.I., Kappos, L., Würfel, J., Granziera, C., Paul, F. and Yaldizli, Ö.
Neurology Neuroimmunology & Neuroinflammation 9 (3): e1147. May 2022

Efficacy and safety of masitinib in progressive forms of multiple sclerosis: a randomized, phase 3, clinical trial.
Vermersch, P., Brieva-Ruiz, L., Fox, R.J., Paul, F., Ramio-Torrenta, L., Schwab, M., Moussy, A., Mansfield, C., Hermine, O. and Maciejowski, M.
Neurology Neuroimmunology & Neuroinflammation 9 (3): e1148. May 2022

Leveraging visual outcome measures to advance therapy development in neuroimmunologic disorders.
Graves, J.S., Oertel, F.C., Van der Walt, A., Collorone, S., Sotirchos, E.S., Pihl-Jensen, G., Albrecht, P., Yeh, E.A., Saidha, S., Frederiksen, J., Newsome, S.D. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 9 (2): e1126. March 2022

Impact of dietary intervention on serum neurofilament light chain in multiple sclerosis.
Bock, M., Steffen, F., Zipp, F. and Bittner, S.
Neurology Neuroimmunology & Neuroinflammation 9 (1): e1102. January 2022

Interleukin-6 receptor blockade in treatment-refractory MOG-IgG-associated disease and neuromyelitis optica spectrum disorders.
Ringelstein, M., Ayzenberg, I., Lindenblatt, G., Fischer, K., Gahlen, A., Novi, G., Hayward-Könnecke, H., Schippling, S., Rommer, P.S., Kornek, B., Zrzavy, T., Biotti, D., Ciron, J., Audoin, B., Berthele, A., Giglhuber, K., Zephir, H., Kümpfel, T., Berger, R., Röther, J., Häußler, V., Stellmann, J.P., Whittam, D., Jacob, A., Kraemer, M., Gueguen, A., Deschamps, R., Bayas, A., Hümmert, M.W., Trebst, C., Haarmann, A., Jarius, S., Wildemann, B., Grothe, M., Siebert, N., Ruprecht, K., Paul, F., Collongues, N., Marignier, R., Levy, M., Karenfort, M., Deppe, M., Albrecht, P., Hellwig, K., Gold, R., Hartung, H.P., Meuth, S.G., Kleiter, I. and Aktas, O.
Neurology Neuroimmunology & Neuroinflammation 9 (1): e1100. January 2022

2021

Retinal optical coherence tomography in neuromyelitis optica.
Oertel, F.C., Specovius, S., Zimmermann, H.G., Chien, C., Motamedi, S., Bereuter, C., Cook, L., Lana Peixoto, M.A., Fontanelle, M.A., Kim, H.J., Hyun, J.W., Palace, J., Roca-Fernandez, A., Leite, M.I., Sharma, S., Ashtari, F., Kafieh, R., Dehghani, A., Pourazizi, M., Pandit, L., D'Cunha, A., Aktas, O., Ringelstein, M., Albrecht, P., May, E., Tongco, C., Leocani, L., Pisa, M., Radaelli, M., Martinez-Lapiscina, E.H., Stiebel-Kalish, H., Siritho, S., de Seze, J., Senger, T., Havla, J., Marignier, R., Cobo-Calvo, A., Bichuetti, D., Tavares, I.M., Asgari, N., Soelberg, K., Altintas, A., Yildirim, R., Tanriverdi, U., Jacob, A., Huda, S., Rimler, Z., Reid, A., Mao-Draayer, Y., Soto de Castillo, I., Petzold, A., Green, A.J., Yeaman, M.R., Smith, T., Brandt, A.U. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 8 (6): e1068. November 2021

Increased serum neurofilament light and thin ganglion cell-inner plexiform layer are additive risk factors for disease activity in early multiple sclerosis.
Lin, T.Y., Vitkova, V., Asseyer, S., Martorell Serra, I., Motamedi, S., Chien, C., Ditzhaus, M., Papadopoulou, A., Benkert, P., Kuhle, J., Bellmann-Strobl, J., Ruprecht, K., Paul, F., Brandt, A.U. and Zimmermann, H.G.
Neurology Neuroimmunology & Neuroinflammation 8 (5): e1051. September 2021

Pain, depression, and quality of life in neuromyelitis optica spectrum disorder: a cross-sectional study of 166 AQP4 antibody-seropositive patients.
Ayzenberg, I., Richter, D., Henke, E., Asseyer, S., Paul, F., Trebst, C., Hümmert, M.W., Havla, J., Kümpfel, T., Ringelstein, M., Aktas, O., Wildemann, B., Jarius, S., Häußler, V., Stellmann, J.P., Senel, M., Klotz, L., Pellkofer, H.L., Weber, M.S., Pawlitzki, M., Rommer, P.S., Berthele, A., Wernecke, K.D., Hellwig, K., Gold, R. and Kleiter, I.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e985. May 2021

Epigallocatechin gallate in relapsing-remitting multiple sclerosis: a randomized, placebo-controlled trial.
Bellmann-Strobl, J., Paul, F., Wuerfel, J., Dörr, J., Infante-Duarte, C., Heidrich, E., Körtgen, B., Brandt, A., Pfüller, C., Radbruch, H., Rust, R., Siffrin, V., Aktas, O., Heesen, C., Faiss, J., Hoffmann, F., Lorenz, M., Zimmermann, B., Groppa, S., Wernecke, K.D. and Zipp, F.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e981. May 2021

Disability outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Marignier, R., Bennett, J.L., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D., Fujihara, K., Paul, F., Cutter, G.R., Green, A.J., Aktas, O., Hartung, H.P., Lublin, F.D., Williams, I.M., Drappa, J., She, D., Cimbora, D., Rees, W., Smith, M., Ratchford, J.N., Katz, E. and Cree, B.A.C.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e978. May 2021

Epigallocatechin gallate in progressive MS: a randomized, placebo-controlled trial.
Rust, R., Chien, C., Scheel, M., Brandt, A.U., Dörr, J., Wuerfel, J., Klumbies, K., Zimmermann, H., Lorenz, M., Wernecke, K.D., Bellmann-Strobl, J. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e964. May 2021

N2 year in review.
Dalmau, J., Dalakas, M.C., Kolson, D.L., Paul, F. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 8 (1): e925. January 2021

2020

Genetic determinants of the humoral immune response in MS.
Gasperi, C., Andlauer, T.F.M., Keating, A., Knier, B., Klein, A., Pernpeintner, V., Lichtner, P., Gold, R., Zipp, F., Then Bergh, F., Stangel, M., Tumani, H., Wildemann, B., Wiendl, H., Bayas, A., Kümpfel, T., Zettl, U.K., Linker, R.A., Ziemann, U., Knop, M., Warnke, C., Friese, M.A., Paul, F., Tackenberg, B., Berthele, A. and Hemmer, B.
Neurology Neuroimmunology & Neuroinflammation 7 (5): e827. September 2020

Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders.
Motamedi, S., Oertel, F.C., Yadav, S.K., Kadas, E.M., Weise, M., Havla, J., Ringelstein, M., Aktas, O., Albrecht, P., Ruprecht, K., Bellmann-Strobl, J., Zimmermann, H.G., Paul, F. and Brandt, A.U.
Neurology Neuroimmunology & Neuroinflammation 7 (5): e805. September 2020

Is APOE ε4 associated with cognitive performance in early MS?
Engel, S., Graetz, C., Salmen, A., Muthuraman, M., Toenges, G., Ambrosius, B., Bayas, A., Berthele, A., Heesen, C., Klotz, L., Kümpfel, T., Linker, R.A., Meuth, S.G., Paul, F., Stangel, M., Tackenberg, B., Then Bergh, F., Tumani, H., Weber, F., Wildemann, B., Zettl, U.K., Antony, G., Bittner, S., Groppa, S., Hemmer, B., Wiendl, H., Gold, R., Zipp, F., Lill, C.M. and Luessi, F.
Neurology Neuroimmunology & Neuroinflammation 7 (4): e728. July 2020

Cortical topological network changes following optic neuritis.
Backner, Y., Ben-Shalom, I., Kuchling, J., Siebert, N., Scheel, M., Ruprecht, K., Brandt, A., Paul, F. and Levin, N.
Neurology Neuroimmunology & Neuroinflammation 7 (3): e687. May 2020

Impact of treatment on cellular immunophenotype in MS: a cross-sectional study.
Cellerino, M., Ivaldi, F., Pardini, M., Rotta, G., Vila, G., Bäcker-Koduah, P., Berge, T., Laroni, A., Lapucci, C., Novi, G., Boffa, G., Sbragia, E., Palmeri, S., Asseyer, S., Høgestøl, E., Campi, C., Piana, M., Inglese, M., Paul, F., Harbo, H.F., Villoslada, P., Kerlero de Rosbo, N. and Uccelli, A.
Neurology Neuroimmunology & Neuroinflammation 7 (3): e693. May 2020

Understanding neurodegenerative changes of the afferent visual pathway in MS.
Zimmermann, H.G. and Oertel, F.C.
Neurology Neuroimmunology & Neuroinflammation 7 (2): e667. March 2020

N2 year in review.
Dalmau, J., Dalakas, M.C., Kolson, D.L., Paul, F. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 7 (1): e644. January 2020

2019

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.
Cook, L.J., Rose, J.W., Alvey, J.S., Jolley, A.M., Kuhn, R., Marron, B., Pederson, M., Enriquez, R., Yearley, J., McKechnie, S., Han, M.H., Tomczak, A.J., Levy, M., Mealy, M.A., Coleman, J., Bennett, J.L., Johnson, R., Barnes-Garcia, M., Traboulsee, A.L., Carruthers, R.L., Lee, L.E., Schubert, J.J., McMullen, K., Kister, I., Rimler, Z., Reid, A., Sicotte, N.L., Planchon, S.M., Cohen, J.A., Ivancic, D., Sedlak, J.L., Sand, I.K., Repovic, P., Amezcua, L., Pruitt, A., Amundson, E., Chitnis, T., Mullin, D.S., Klawiter, E.C., Russo, A.W., Riley, C.S., Onomichi, K.B., Levine, L., Nelson, K.E., Nealon, N.M., Engel, C., Kruse-Hoyer, M., Marcille, M., Tornes, L., Rumpf, A., Greer, A., Kenneally Behne, M., Rodriguez, R.R., Behne, D.W., Blackway, D.W., Coords, B., Blaschke, T.F., Sheard, J., Smith, T.J., Behne, J.M. and Yeaman, M.R.
Neurology Neuroimmunology & Neuroinflammation 6 (5): e583. September 2019

Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
Stiebel-Kalish, H., Hellmann, M.A., Mimouni, M., Paul, F., Bialer, O., Bach, M. and Lotan, I.
Neurology Neuroimmunology & Neuroinflammation 6 (4): e572. July 2019

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.
Pasquier, B., Borisow, N., Rasche, L., Bellmann-Strobl, J., Ruprecht, K., Niendorf, T., Derfuss, T.J., Wuerfel, J., Paul, F. and Sinnecker, T.
Neurology Neuroimmunology & Neuroinflammation 6 (3): e541. May 2019

N2 year in review and message from the editor to our reviewers.
Dalmau, J., Kolson, D.L., Paul, F. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 6 (1): e525. January 2019

Gadolinium in human brain sections and colocalization with other elements.
El-Khatib, A.H., Radbruch, H., Trog, S., Neumann, B., Paul, F., Koch, A., Linscheid, M.W., Jakubowski, N. and Schellenberger, E.
Neurology Neuroimmunology & Neuroinflammation 6 (1): e515. January 2019

2018

Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions.
Kleiter, I., Gahlen, A., Borisow, N., Fischer, K., Wernecke, K.D., Hellwig, K., Pache, F., Ruprecht, K., Havla, J., Kümpfel, T., Aktas, O., Hartung, H.P., Ringelstein, M., Geis, C., Kleinschnitz, C., Berthele, A., Hemmer, B., Angstwurm, K., Stellmann, J.P., Schuster, S., Stangel, M., Lauda, F., Tumani, H., Mayer, C., Krumbholz, M., Zeltner, L., Ziemann, U., Linker, R., Schwab, M., Marziniak, M., Then Bergh, F., Hofstadt-van Oy, U., Neuhaus, O., Zettl, U.K., Faiss, J., Wildemann, B., Paul, F., Jarius, S. and Trebst, C.
Neurology Neuroimmunology & Neuroinflammation 5 (6): e504. November 2018

Temporal visual resolution and disease severity in MS.
Ayadi, N., Dörr, J., Motamedi, S., Gawlik, K., Bellmann-Strobl, J., Mikolajczak, J., Brandt, A.U., Zimmermann, H. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 5 (5): e492. 1 September 2018

VZV-associated acute retinal necrosis in a patient with MS treated with natalizumab.
Pawlitzki, M., Teuber, J., Campe, C., Wagner, M., Schuart, C., Paul, F. and Bittner, D.
Neurology Neuroimmunology & Neuroinflammation 5 (5): e475. 1 September 2018

Multicenter reliability of semiautomatic retinal layer segmentation using OCT.
Oberwahrenbrock, T., Traber, G.L., Lukas, S., Gabilondo, I., Nolan, R., Songster, C., Balk, L., Petzold, A., Paul, F., Villoslada, P., Brandt, A.U., Green, A.J. and Schippling, S.
Neurology Neuroimmunology & Neuroinflammation 5 (3): e449. 1 May 2018

Treatment choices and neuropsychological symptoms of a large cohort of early MS.
von Bismarck, O., Dankowski, T., Ambrosius, B., Hessler, N., Antony, Gi., Ziegler, A., Hoshi, M.M., Aly, L., Luessi, F., Groppa, S., Klotz, L., Meuth, S.G., Tackenberg, B., Stoppe, M., Then Bergh, F., Tumani, H., Kümpfel, T., Stangel, M., Heesen, C., Wildemann, B., Paul, F., Bayas, A., Warnke, C., Weber, F., Linker, R.A., Ziemann, U., Zettl, U.K., Zipp, F., Wiendl, H., Hemmer, B., Gold, R. and Salmen, A.
Neurology Neuroimmunology & Neuroinflammation 5 (3): e446. 1 May 2018

Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue.
Gaede, G., Tiede, M., Lorenz, I., Brandt, A.U., Pfueller, C., Dörr, J., Bellmann-Strobl, J., Piper, S.K., Roth, Y., Zangen, A., Schippling, S. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 5 (1): e423. 1 January 2018

2017

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.
Asgari, N., Flanagan, E.P., Fujihara, K., Kim, H.J., Skejoe, H.P., Wuerfel, J., Kuroda, H., Kim, S.H., Maillart, E., Marignier, R., Pittock, S.J., Paul, F. and Weinshenker, B.G.
Neurology Neuroimmunology & Neuroinflammation 4 (4): e343. July 2017

Olfactory dysfunction in patients with primary progressive MS.
Schmidt, F.A., Maas, M.B., Geran, R., Schmidt, C., Kunte, H., Ruprecht, K., Paul, F., Göktas, Ö. and Harms, L.
Neurology Neuroimmunology & Neuroinflammation 4 (4): e369. July 2017

Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study.
Bove, R., Elsone, L., Alvarez, E., Borisow, N., Cortez, M.M., Mateen, F.J., Mealy, M.A., Mutch, K., Tobyne, S., Ruprecht, K., Buckle, G., Levy, M., Wingerchuk, D.M., Paul, F., Cross, A.H., Weinshenker, B., Jacob, A., Klawiter, E.C. and Chitnis, T.
Neurology Neuroimmunology & Neuroinflammation 4 (3): e339. May 2017

Microstructural visual system changes in AQP4-antibody-seropositive NMOSD.
Oertel, F.C., Kuchling, J., Zimmermann, H., Chien, C., Schmidt, F., Knier, B., Bellmann-Strobl, J., Korn, T., Scheel, M., Klistorner, A., Ruprecht, K., Paul, F. and Brandt, A.U.
Neurology Neuroimmunology & Neuroinflammation 4 (3): e334. May 2017

Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD.
Oertel, F.C., Zimmermann, H., Mikolajczak, J., Weinhold, M., Kadas, E.M., Oberwahrenbrock, T., Pache, F., Bellmann-Strobl, J., Ruprecht, K., Paul, F. and Brandt, A.U.
Neurology Neuroimmunology & Neuroinflammation 4 (3): e338. May 2017

2016

Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.
Chavarro, V.S., Mealy, M.A., Simpson, A., Lacheta, A., Pache, F., Ruprecht, K., Gold, S.M., Paul, F., Brandt, A.U. and Levy, M.
Neurology Neuroimmunology & Neuroinflammation 3 (6): e286. December 2016

MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T.
Sinnecker, T., Schumacher, S., Mueller, K., Pache, F., Dusek, P., Harms, L., Ruprecht, K., Nytrova, P., Chawla, S., Niendorf, T., Kister, I., Paul, F., Ge, Y. and Wuerfel, J.
Neurology Neuroimmunology & Neuroinflammation 3 (4): e259. August 2016

Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer.
Soelberg, K., Larsen, S.R., Moerch, M.T., Thomassen, M., Brusgaard, K., Paul, F., Smith, T.J., Godballe, C., Grauslund, J., Lillevang, S.T. and Asgari, N.
Neurology Neuroimmunology & Neuroinflammation 3 (4): e252. August 2016

Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI.
Blaabjerg, M., Ruprecht, K., Sinnecker, T., Kondziella, D., Niendorf, T., Kerrn-Jespersen, B.M., Lindelof, M., Lassmann, H., Kristensen, B.W., Paul, F. and Illes, Z.
Neurology Neuroimmunology & Neuroinflammation 3 (3): e226. June 2016

Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.
Finke, C., Heine, J., Pache, F., Lacheta, A., Borisow, N., Kuchling, J., Bellmann-Strobl, J., Ruprecht, K., Brandt, A.U. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 3 (3): e229. June 2016

Visual dysfunction, but not retinal thinning, following anti-NMDA receptor encephalitis.
Brandt, A.U., Oberwahrenbrock, T., Mikolajczak, J., Zimmermann, H., Prüss, H., Paul, F. and Finke, C.
Neurology Neuroimmunology & Neuroinflammation 3 (2): e198. April 2016

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.
Metz, I., Beißbarth, T., Ellenberger, D., Pache, F., Stork, L., Ringelstein, M., Aktas, O., Jarius, S., Wildemann, B., Dihazi, H., Friede, T., Brück, W., Ruprecht, K. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 3 (2): e204. April 2016

2015

7T MRI in natalizumab-associated PML and ongoing MS disease activity: a case study.
Sinnecker, T., Othman, J., Kühl, M., Mekle, R., Selbig, I., Niendorf, T., Kunkel, A., Wienecke, P., Kern, P., Paul, F., Faiss, J. and Wuerfel, J.
Neurology Neuroimmunology & Neuroinflammation 2 (6): e171. December 2015

Effects of diazoxide in multiple sclerosis: a randomized, double-blind phase 2 clinical trial.
Villoslada, P., Rovira, A., Montalban, X., Arroyo, R., Paul, F., Meca-Lallana, V., Ramo, C., Fernandez, O., Saiz, A., Garcia-Merino, A., Ramió-Torrentà, L., Casanova, B., Oreja-Guevara, C., Muñoz, D., Martinez-Rodriguez, J.E., Lensch, E., Prieto, J.M., Meuth, S.G., Nuñez, X., Campás, C. and Pugliese, M.
Neurology Neuroimmunology & Neuroinflammation 2 (5): e147. October 2015

Update on biomarkers in neuromyelitis optica.
Melamed, E., Levy, M., Waters, P.J., Sato, D.K., Bennett, J.L., John, G.R., Hooper, D.C., Saiz, A., Bar-Or, A., Kim, H.J., Pandit, L., Leite, M.I., Asgari, N., Kissani, N., Hintzen, R., Marignier, R., Jarius, S., Marcelletti, J., Smith, T.J., Yeaman, M.R. and Han, M.H.
Neurology Neuroimmunology & Neuroinflammation 2 (4): e134. 23 July 2015

Does Nrf2 help nerves to survive?
Ruprecht, K. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 2 (3): e105. June 2015